-Outlook Doha: The climate talks here in the Qatari capital limped into its final week today with hard close-door negotiations yet to yield any visible outcomes amid warnings from highly vulnerable nations that time was running out. The talks have a crucial agenda to decide a treaty which could replace the Kyoto Protocol besides ensuring that the parties to the pact commit to ambitions under the second commitment period which will come...

-The Times of India The cost of air-conditioners and refrigerators could go up considerably starting next summer if the US and other rich countries force a decision at the UN climate talks in November at Doha, to order a global ban on existing refrigerant gases and replace them with costly though relatively more climate-friendly alternatives. One of the alternatives being proposed is produced jointly by DuPont and Honeywell, two US-based multinationals, and...

-The Times of India Get ready to shell out more for your train journey and several other services provided by the government — from parcels to patents. Pawan Kumar Bansal, the new railway minister, on Monday hinted at an increase in passenger fares with a caveat that it was not meant to earn a profit for the state-run transporter. "Fares will not be increased for the sake of increasing fare. If fare...

-IPS News Environmental activists are cautiously optimistic that a call by a court-appointed technical committee for a ten-year moratorium on open field trials of genetically modified (GM) crops will shelve plans to introduce bio-engineered foods in this largely agricultural country. “We are now waiting to see whether the Supreme Court will accept the recommendations of its own committee at the next hearing on Oct. 29,” said Devinder Sharma, chairman of the Forum...

-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...